Treatment - Page 45 of 471 Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Evaluating the long-term outcomes of patients with HL receiving intensified treatment

Evaluating the long-term outcomes of patients with HL receiving intensified treatment

Posted by on Jul 31, 2021 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to evaluate the long-term effectiveness and safety of high-dose chemotherapy (HDC) for the treatment of patients with unfavorable Hodgkin lymphoma (HL). The authors concluded that HDC increased the control of the disease in the long-term. Some background HDC with radiotherapy is a standard treatment of HL. 4 cycles of...

Read More

Comparing the effects of oral hyaluronic acid combined with injections against injections alone for the treatment of Peyronie’s disease.

Comparing the effects of oral hyaluronic acid combined with injections against injections alone for the treatment of Peyronie’s disease.

Posted by on Jul 31, 2021 in Erectile dysfunction | 0 comments

In a nutshell This study aimed to compare the effects of oral hyaluronic acid (HA) and injections of HA into the scar tissues plaque, against the effects of injections alone in Peyronie's disease (PD). The results suggest that the combination treatment was more effective than injections alone. Some background PD is a noncancerous condition...

Read More

Does prostate size count with bipolar transurethral enucleation of the prostate in patients with benign prostatic hyperplasia?

Does prostate size count with bipolar transurethral enucleation of the prostate in patients with benign prostatic hyperplasia?

Posted by on Jul 31, 2021 in Benign prostatic hyperplasia | 0 comments

In a nutshell The authors examined the relationship between prostate size and surgical outcomes following bipolar transurethral enucleation of the prostate (B-TUEP). The authors found that B-TUEP provided symptom relief regardless of prostate size in men with benign prostatic hyperplasia (BPH). Some background BPH is the non-cancerous...

Read More

Is selpercatinib effective in treating brain metastases in RET fusion-positive non-small cell lung cancer?

Is selpercatinib effective in treating brain metastases in RET fusion-positive non-small cell lung cancer?

Posted by on Jul 31, 2021 in Lung cancer | 0 comments

In a nutshell This study looked at the effectiveness selpercatinib (Retevmo) for the treatment of patients with RET fusion-positive non-small cell lung cancer (NSCLC) that has spread to the brain. The authors found that selpercatinib was effective in these patients.  Some background RET mutations are genetic abnormalities that can cause some...

Read More

Evaluating outcomes of laparoscopic surgery for the treatment of elderly patients over 80 years with colorectal cancer.

Evaluating outcomes of laparoscopic surgery for the treatment of elderly patients over 80 years with colorectal cancer.

Posted by on Jul 31, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the short- and long-term outcomes of laparoscopic surgery (LS; keyhole surgery) for the treatment of elderly patients with colorectal cancer (CRC) aged over 80 years. The data showed that LS is a good and safe option for these patients. Some background Colorectal cancer (CRC) is one of the most common types of cancer...

Read More

Aromatase inhibitors versus tamoxifen following chemotherapy for perimenopausal women with breast cancer

Aromatase inhibitors versus tamoxifen following chemotherapy for perimenopausal women with breast cancer

Posted by on Jul 31, 2021 in Breast cancer | 0 comments

In a nutshell This study was carried out to assess the use of aromatase inhibitors (AI) versus tamoxifen (Novaldex) for women before menopause with estrogen receptor-positive (ER+) breast cancer (BC). The authors found that AIs were associated with better outcomes than tamoxifen in these patients.  Some background About 80% of all BCs...

Read More

Comparing outcomes for prostate surgery versus radiation therapy for localized prostate cancer

Comparing outcomes for prostate surgery versus radiation therapy for localized prostate cancer

Posted by on Jul 31, 2021 in Prostate cancer | 0 comments

In a nutshell The study aimed to compare the effectiveness of surgery versus radiation therapy for patients with high-grade localized prostate cancer (PCa). The study concluded that surgery was associated with improved survival compared to radiation therapy in these patients. Some background Prostate cancer (PCa) is the second most common...

Read More

Is switching first-line targeted therapy for rheumatoid arthritis within 6 months of not reaching disease remission better than a traditional approach?

Is switching first-line targeted therapy for rheumatoid arthritis within 6 months of not reaching disease remission better than a traditional approach?

Posted by on Jul 25, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether switching a first-line targeted therapy (TT) within 6 months of not attaining low disease activity (LDA) enhances the chance of patients with rheumatoid arthritis (RA) achieving their target at the 12-month visit. The data showed an increased chance of achieving a target of remission or LDA at the...

Read More

Comparing second-line therapy options combined with metformin for patients with type 2 diabetes.

Comparing second-line therapy options combined with metformin for patients with type 2 diabetes.

Posted by on Jul 25, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study explored the effects of different second-line therapies combined with metformin (Glucophage) in patients with type 2 diabetes (T2D). The data showed that metformin combinations with a sulfonylurea (SU) had the lowest weight loss, the smallest effect of lowering blood glucose, and an overall, reduced health...

Read More

Comparing outcomes of donors for a second allogenic stem cell transplant for patients with acute lymphoblastic leukemia

Comparing outcomes of donors for a second allogenic stem cell transplant for patients with acute lymphoblastic leukemia

Posted by on Jul 25, 2021 in Leukemia | 0 comments

In a nutshell This study aimed to compare outcomes of donor types for a second allogeneic stem cell transplant (alloSCT) in patients with relapsed acute lymphoblastic leukemia (ALL).  This study concluded that there is no major difference in overall survival between a matched unrelated donor (MUD) and a half-matched donor (HMD) in...

Read More

Health-related quality of life in patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab

Health-related quality of life in patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab

Posted by on Jul 25, 2021 in Leukemia | 0 comments

In a nutshell The study aimed to investigate the health-related quality of life (HR-QoL) for patients with chronic lymphocytic leukemia (CLL) who were treated with venetoclax (VEN; Venclexta) and obinutuzumab (Obi; Gazyva).  This study concluded that this treatment is effective and does not impair the quality of life in these...

Read More